Aging, Geriatric Syndromes and Clonal Hematopoiesis
Purpose
In this study the investigators will incorporate a wide range of clinical variables
associated with aging and cardiovascular disease to determine whether they are associated
with mutation status independent of chronologic age. Clinically, aging can be
operationalized using geriatric assessment, which entails a comprehensive
multi-dimensional assessment of the health of an older adult, including measures of
comorbidity, polypharmacy, functional status, cognition, depression, falls, social
activities and social support. Given that aging is heterogeneous, geriatric assessment
allows greater specificity for aging than chronological age alone.
Conditions
- Geriatrics
- Aged
- Geriatric Syndromes
- Cardiovascular Diseases
Eligibility
- Eligible Ages
-
Over 50 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
-
Yes
Inclusion Criteria
- At least 50 years of age.
- Able to understand written and spoken English.
- Able to understand and willing to sign an IRB-approved written informed consent
document (or that of a legally authorized representative, if applicable for the
trauma cohort)
Exclusion Criteria
- Inability or unwillingness to complete health questionnaire.
- History of a recent (<30 days) acute viral illness.
- Current cancer diagnosis and currently receiving chemotherapy or undergoing
radiation therapy. A prior history of cancer is allowed if the participant completed
therapy > 1 year prior to enrollment; participants with a prior diagnosis of cancer
will be asked to sign a release of information for the research team to obtain
records regarding their prior cancer treatment.
- Current use of drugs that cause DNA damage (e.g. Cytoxan, azathioprine, etc.) for
the treatment of a non-malignant disease.
- Vulnerable populations (e.g. prisoners).
- Known infection with Hepatitis B or C, HTLV, or HIV.
- Additional exclusion for optional bone marrow aspirate/biopsy substudy:
- Use of medications for anticoagulation or "blood thinning" including warfarin,
low molecular weight heparins (enoxaparin, daltaparin) or direct-acting oral
anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban or betrixaban)
- allergy to lidocaine or other local anesthetics.
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|
Arm A: Clonal hematopoiesis
|
- Complete several self-administered health assessments at baseline and every 6 months
until death.
- Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight
will be performed by a member of the research team at baseline and every 6 months
until death.
- Peripheral blood draw will occur at baseline and no more than every 6 months until
death.
- Buccal swabs will occur at baseline and repeated as necessary, but not more than
every 6 months until death
- May be approached about optional bone marrow biopsy
|
-
Other: Cognitive Assessment
-Baseline and no more frequently than every 6 months until death
-
Other: Activities of Daily Living Questionnaire
- 10 items about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Instrumental Activities of Daily Living, subscale of the OARS
- 7 items about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Karnofsky Self-reported Performance Rating Scale
- 1 item about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Number of Falls
- 1 item about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Physical Health Section, subscale of the OARS
- 13 items about comorbidity
- Baseline and no more frequently than every 6 months until death
-
Other: MOS Social Activity Survey
- 4 items about social activity
- Baseline and no more frequently than every 6 months until death
-
Other: Unintentional Weight Loss
- 2 items about nutrition
- Baseline and no more frequently than every 6 months until death
-
Genetic: Peripheral Blood Draw
-Baseline and no more frequently than every 6 months until death
-
Genetic: Buccal Swab
- Participants will rinse their mouths 2 times with water for 20-30 seconds and
discard the expectorated sample. One side of the inner cheek (buccal mucosa) will
then be scraped with a cotton swab 20 times (alternatively, the tongue will be
brushed 20 times with a toothbrush)
- Baseline and no more frequently than every 6 months until death
-
Other: Heart Health and Smoking History from BRFSS questionnaire
- 7 items about heart health and smoking history
- Baseline and no more frequently than every 6 months until death
-
Other: Gait Speed
- Research coordinator will test gait speed
- Baseline and no more frequently than every 6 months until death
-
Other: Grip Strength
- Research coordinator will test grip strength
- Baseline and no more frequently than every 6 months until death
-
Other: Height and Weight measurements
-Baseline and no more frequently than every 6 months until death
-
Other: Blood pressure measurement
-Baseline and no more frequently than every 6 months until death
-
Procedure: Optional bone marrow biopsy
-1 optional bone marrow biopsy
|
|
Arm B: No clonal hematopoiesis
|
- Complete several self-administered health assessments at baseline and every 6 months
until death.
- Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight
will be performed by a member of the research team at baseline and every 6 months
until death.
- Peripheral blood draw will occur at baseline and no more than every 6 months until
death.
- Buccal swabs will occur at baseline and repeated as necessary, but not more than
every 6 months until death
- May be approached about optional bone marrow biopsy
|
-
Other: Cognitive Assessment
-Baseline and no more frequently than every 6 months until death
-
Other: Activities of Daily Living Questionnaire
- 10 items about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Instrumental Activities of Daily Living, subscale of the OARS
- 7 items about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Karnofsky Self-reported Performance Rating Scale
- 1 item about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Number of Falls
- 1 item about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Physical Health Section, subscale of the OARS
- 13 items about comorbidity
- Baseline and no more frequently than every 6 months until death
-
Other: MOS Social Activity Survey
- 4 items about social activity
- Baseline and no more frequently than every 6 months until death
-
Other: Unintentional Weight Loss
- 2 items about nutrition
- Baseline and no more frequently than every 6 months until death
-
Genetic: Peripheral Blood Draw
-Baseline and no more frequently than every 6 months until death
-
Genetic: Buccal Swab
- Participants will rinse their mouths 2 times with water for 20-30 seconds and
discard the expectorated sample. One side of the inner cheek (buccal mucosa) will
then be scraped with a cotton swab 20 times (alternatively, the tongue will be
brushed 20 times with a toothbrush)
- Baseline and no more frequently than every 6 months until death
-
Other: Heart Health and Smoking History from BRFSS questionnaire
- 7 items about heart health and smoking history
- Baseline and no more frequently than every 6 months until death
-
Other: Gait Speed
- Research coordinator will test gait speed
- Baseline and no more frequently than every 6 months until death
-
Other: Grip Strength
- Research coordinator will test grip strength
- Baseline and no more frequently than every 6 months until death
-
Other: Height and Weight measurements
-Baseline and no more frequently than every 6 months until death
-
Other: Blood pressure measurement
-Baseline and no more frequently than every 6 months until death
-
Procedure: Optional bone marrow biopsy
-1 optional bone marrow biopsy
|
|
Arm C: No clonal hematopoiesis & no follow-up
|
- Complete several self-administered health assessments at baseline with no further
follow-up
- Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight
will be performed by a member of the research team at baseline with no further
follow-up
- Peripheral blood draw will occur at baseline with no further follow-up
- Buccal swabs will occur at baseline with no further follow-up
|
-
Other: Cognitive Assessment
-Baseline and no more frequently than every 6 months until death
-
Other: Activities of Daily Living Questionnaire
- 10 items about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Instrumental Activities of Daily Living, subscale of the OARS
- 7 items about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Karnofsky Self-reported Performance Rating Scale
- 1 item about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Number of Falls
- 1 item about daily functional status
- Baseline and no more frequently than every 6 months until death
-
Other: Physical Health Section, subscale of the OARS
- 13 items about comorbidity
- Baseline and no more frequently than every 6 months until death
-
Other: MOS Social Activity Survey
- 4 items about social activity
- Baseline and no more frequently than every 6 months until death
-
Other: Unintentional Weight Loss
- 2 items about nutrition
- Baseline and no more frequently than every 6 months until death
-
Genetic: Peripheral Blood Draw
-Baseline and no more frequently than every 6 months until death
-
Genetic: Buccal Swab
- Participants will rinse their mouths 2 times with water for 20-30 seconds and
discard the expectorated sample. One side of the inner cheek (buccal mucosa) will
then be scraped with a cotton swab 20 times (alternatively, the tongue will be
brushed 20 times with a toothbrush)
- Baseline and no more frequently than every 6 months until death
-
Other: Heart Health and Smoking History from BRFSS questionnaire
- 7 items about heart health and smoking history
- Baseline and no more frequently than every 6 months until death
-
Other: Gait Speed
- Research coordinator will test gait speed
- Baseline and no more frequently than every 6 months until death
-
Other: Grip Strength
- Research coordinator will test grip strength
- Baseline and no more frequently than every 6 months until death
-
Other: Height and Weight measurements
-Baseline and no more frequently than every 6 months until death
-
Other: Blood pressure measurement
-Baseline and no more frequently than every 6 months until death
|
|
Arm D: Hip replacement
|
- Complete several self-administered health assessments at baseline and every 6 months
until death.
- Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight
will be performed by a member of the research team at baseline and every 6 months
until death.
- Participants with or without clonal hematopoiesis who are undergoing hip replacement
- Peripheral blood draw will occur at baseline and no more than every 6 months until
death.
- Buccal swabs will occur at baseline and repeated as necessary, but not more than
every 6 months until death
- May be approached about optional bone marrow biopsy
|
|
|
Arm E: Trauma
|
-Blood sample at the time of admission with initial bloodwork. For inpatient
participants, weekly follow-up samples will be drawn with morning phlebotomy. A follow-up
sample collection will occur 4-7 weeks after discharge.
|
-
Procedure: Blood draw for trauma measurements
-For Arm E only
|
Recruiting Locations
Washington University in St. Louis and nearby locations
Washington University School of Medicine
St Louis 4407066,
Missouri 4398678
63110
More Details
- NCT ID
- NCT02604563
- Status
- Recruiting
- Sponsor
- Washington University School of Medicine
Study Contact
Meagan Jacoby, M.D.
314-747-8439
mjacoby@wustl.edu
Notice
Study information shown on this site is derived from
ClinicalTrials.gov (a public registry operated by the National Institutes of Health).
The listing of studies provided is not certain to be all studies for which you might be eligible.
Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.